An electronic system that stimulates the nerve of the diaphragm muscles has received approval from the Food and Drug Administration (FDA) for use in patients with Amyotrophic Lateral Sclerosis (ALS), ...
September 30, 2011 — The US Food and Drug Administration (FDA) has granted approval for the use of the NeuRx Diaphragm Pacing System to aid breathing in patients with amyotrophic lateral sclerosis ...
ALS patients using diaphragm pacing experienced improved quality of life, with better sleep and daytime functioning, better breathing, and less fatigue. Respiratory failure is one of the major ...
April 19, 2005 — Implantation of a minimally invasive diaphragm pacing system (DPS) with therapeutic electrostimulation may help maintain diaphragm function and slow or arrest the rate of respiratory ...
The U.S. Food and Drug Administration (FDA) has approved the NeuRx Diaphragm Pacing System (DPS) for spinal cord-injured patients who are dependent on ventilators for breathing. The light-weight, ...
Synapse Biomedical Inc. has won breakthrough device designation from the FDA for its Transaeris system, a diaphragm pacing system (DPS) for use in weaning patients off mechanical ventilation. The ...
Synapse Biomedical Inc. has won breakthrough device designation from the FDA for its Transaeris system, a diaphragm pacing system (DPS) for use in weaning patients off mechanical ventilation. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results